Search

everythinglearnresearchcommunity

for

Search:↓

Female hair loss linked to metabolic syndrome, not in males.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Hair restoration surgery has advanced, focusing on natural results and may improve further with new techniques and therapies.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

Dihydrotestosterone affects hair growth by changing the Wnt/β-catenin pathway, with low levels helping and high levels hindering growth.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

No link found between specific genes and female pattern hair loss.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Thai rice bran extracts, especially from Tubtim Chumphae rice, can significantly reduce the activity of hair loss genes, with x-tocopherol showing potential as an anti-hair loss product.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Balding and low testosterone increase risk of urinary stones.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Ciproterone acetate improves hair regrowth and acne in most female patients.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

SFRP2 and PTGDS may be key factors in female hair loss.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

Genetic mutations can affect female sexual development, requiring personalized medical care.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Female hair loss patients more likely to have dry eye and gland issues.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Removing part of the vitamin D receptor stops vitamin D from working properly.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.